421 related articles for article (PubMed ID: 24389087)
21. Assessment of cytotoxicity of quantum dots and gold nanoparticles using cell-based impedance spectroscopy.
Male KB; Lachance B; Hrapovic S; Sunahara G; Luong JH
Anal Chem; 2008 Jul; 80(14):5487-93. PubMed ID: 18553941
[TBL] [Abstract][Full Text] [Related]
22. Gold nanoparticle surface functionalization: a necessary requirement in the development of novel nanotherapeutics.
Nicol JR; Dixon D; Coulter JA
Nanomedicine (Lond); 2015; 10(8):1315-26. PubMed ID: 25955125
[TBL] [Abstract][Full Text] [Related]
23. Inorganic nanomedicine--part 1.
Sekhon BS; Kamboj SR
Nanomedicine; 2010 Aug; 6(4):516-22. PubMed ID: 20417313
[TBL] [Abstract][Full Text] [Related]
24. A perspective on bioconjugated nanoparticles and quantum dots.
Huo Q
Colloids Surf B Biointerfaces; 2007 Sep; 59(1):1-10. PubMed ID: 17544637
[TBL] [Abstract][Full Text] [Related]
25. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology.
Cheon J; Lee JH
Acc Chem Res; 2008 Dec; 41(12):1630-40. PubMed ID: 18698851
[TBL] [Abstract][Full Text] [Related]
26. Cadmium-based quantum dot induced autophagy formation for cell survival via oxidative stress.
Luo YH; Wu SB; Wei YH; Chen YC; Tsai MH; Ho CC; Lin SY; Yang CS; Lin P
Chem Res Toxicol; 2013 May; 26(5):662-73. PubMed ID: 23617821
[TBL] [Abstract][Full Text] [Related]
27. Dendrimer-based organic/inorganic hybrid nanoparticles in biomedical applications.
Shen M; Shi X
Nanoscale; 2010 Sep; 2(9):1596-610. PubMed ID: 20820690
[TBL] [Abstract][Full Text] [Related]
28. Biomedical applications of plasmon resonant metal nanoparticles.
Liao H; Nehl CL; Hafner JH
Nanomedicine (Lond); 2006 Aug; 1(2):201-8. PubMed ID: 17716109
[TBL] [Abstract][Full Text] [Related]
29. Inorganic nanoparticles in diagnosis and treatment of breast cancer.
Núñez C; Estévez SV; Del Pilar Chantada M
J Biol Inorg Chem; 2018 May; 23(3):331-345. PubMed ID: 29453558
[TBL] [Abstract][Full Text] [Related]
30. Pleiotropic functions of antioxidant nanoparticles for longevity and medicine.
Narayanan KB; Park HH
Adv Colloid Interface Sci; 2013 Dec; 201-202():30-42. PubMed ID: 24206941
[TBL] [Abstract][Full Text] [Related]
31. Inorganic nanoparticle-based drug codelivery nanosystems to overcome the multidrug resistance of cancer cells.
Chen Y; Chen H; Shi J
Mol Pharm; 2014 Aug; 11(8):2495-510. PubMed ID: 24224544
[TBL] [Abstract][Full Text] [Related]
32. Gold nanoparticles: a paradigm shift in biomedical applications.
Khan MS; Vishakante GD; Siddaramaiah H
Adv Colloid Interface Sci; 2013 Nov; 199-200():44-58. PubMed ID: 23871224
[TBL] [Abstract][Full Text] [Related]
33. Low-toxic and safe nanomaterials by surface-chemical design, carbon nanotubes, fullerenes, metallofullerenes, and graphenes.
Yan L; Zhao F; Li S; Hu Z; Zhao Y
Nanoscale; 2011 Feb; 3(2):362-82. PubMed ID: 21157592
[TBL] [Abstract][Full Text] [Related]
34. Enabling biomedical research with designer quantum dots.
Tomczak N; Jańczewski D; Dorokhin D; Han MY; Vancso GJ
Methods Mol Biol; 2012; 811():245-65. PubMed ID: 22042684
[TBL] [Abstract][Full Text] [Related]
35. Inorganic materials using 'unusual' microorganisms.
Bansal V; Bharde A; Ramanathan R; Bhargava SK
Adv Colloid Interface Sci; 2012 Nov; 179-182():150-68. PubMed ID: 22818492
[TBL] [Abstract][Full Text] [Related]
36. Bioresponsive peptide-inorganic hybrid nanomaterials.
Aili D; Stevens MM
Chem Soc Rev; 2010 Sep; 39(9):3358-70. PubMed ID: 20596582
[TBL] [Abstract][Full Text] [Related]
37. Nanomedicines for Renal Management: From Imaging to Treatment.
Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W
Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331
[TBL] [Abstract][Full Text] [Related]
38. Toxicity of novel nanosized formulations used in medicine.
El-Ansary A; Al-Daihan S; Bacha AB; Kotb M
Methods Mol Biol; 2013; 1028():47-74. PubMed ID: 23740113
[TBL] [Abstract][Full Text] [Related]
39. Long-term tracking of cells using inorganic nanoparticles as contrast agents: are we there yet?
Taylor A; Wilson KM; Murray P; Fernig DG; Lévy R
Chem Soc Rev; 2012 Apr; 41(7):2707-17. PubMed ID: 22362426
[TBL] [Abstract][Full Text] [Related]
40. Quantum dot cytotoxicity and ways to reduce it.
Winnik FM; Maysinger D
Acc Chem Res; 2013 Mar; 46(3):672-80. PubMed ID: 22775328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
